WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H524654
CAS#: 166196-11-8
Description: CGP-47292 is a metabolite of the novel anti-epileptic compound, CGP 33,101.
Hodoodo Cat#: H524654
Name: CGP-47292
CAS#: 166196-11-8
Chemical Formula: C10H7F2N3O2
Exact Mass: 239.05
Molecular Weight: 239.180
Elemental Analysis: C, 50.22; H, 2.95; F, 15.89; N, 17.57; O, 13.38
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: CGP-47292; CGP 47292; CGP47292; UNII-266244C47B; CGP 47,292.
IUPAC/Chemical Name: 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid
InChi Key: OPJHWTKDQYKYHL-UHFFFAOYSA-N
InChi Code: InChI=1S/C10H7F2N3O2/c11-7-2-1-3-8(12)6(7)4-15-5-9(10(16)17)13-14-15/h1-3,5H,4H2,(H,16,17)
SMILES Code: c1cc(c(c(c1)F)Cn2cc(nn2)C(=O)O)F
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 239.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Rouan MC, Souppart C, Alif L, Moes D, Lecaillon JB, Godbillon J. Automated analysis of a novel anti-epileptic compound, CGP 33,101, and its metabolite, CGP 47,292, in body fluids by high-performance liquid chromatography and liquid-solid extraction. J Chromatogr B Biomed Appl. 1995 May 19;667(2):307-13. PubMed PMID: 7663704.
2: Inoue NR, Hall A, Lai WG, Williams ET. Reversible inhibition of human carboxylesterases by acyl glucuronides. Drug Metab Dispos. 2013 Apr;41(4):698-703. doi: 10.1124/dmd.112.050252. Epub 2013 Feb 5. PubMed PMID: 23386702.
